Target intelligence / Profile preview

2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) radical cation (ABTS radical cation) (ABTS•+)

Target
ABTS•+
Molecular classification
Chemical reagent, Free radical, Organic cation
01

Overview

ABTS (2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)) radical cation is a stable free radical used extensively in biochemical research to evaluate the total antioxidant capacity (TAC) of various substances (PubChem CID 5360881). It is generated by the oxidation of ABTS with an oxidizing agent like potassium persulfate (Re et al., 1999). In the presence of hydrogen-donating antioxidants, the blue-green chromophore of the ABTS radical is reduced back to its colorless neutral form (ScienceDirect). This reduction can be measured spectrophotometrically at specific wavelengths, typically 734 nm, to quantify the antioxidant potential of a sample (NIH/PubMed). While it serves as a critical tool for screening potential therapeutic agents with antioxidant properties, it is not a biological target found within the human body. Consequently, it does not play a direct role in disease pathology or physiological signaling. Its primary utility lies in the standardization of antioxidant activity measurements relative to a reference compound like Trolox, often referred to as the Trolox Equivalent Antioxidant Capacity (TEAC) assay (Wikipedia). It is not considered a drug target for therapeutic intervention but rather a diagnostic or analytical reagent.

Other names
ABTS radicalABTS cation radical2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt radicalABTS•+
02

Mechanism of action

Reduction of the ABTS radical cation by electron or hydrogen atom transfer from antioxidant molecules, resulting in the loss of its characteristic blue-green color.

03

Biological functions

In vitro antioxidant capacity measurement
04

Safety considerations

Not a therapeutic targetChemical irritant to skin and eyesPotential toxicity if ingested in laboratory settings
05

Interacting drugs

Ascorbic acid

4 more in the full profile.

Beyond the preview

Go deeper on 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) radical cation (ABTS radical cation) (ABTS•+).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) radical cation (ABTS radical cation) (ABTS•+).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call